Overview
Delcath Systems, Inc., based in the United States, operates within the healthcare industry, focusing primarily on specialty pharmaceuticals and medical devices. The company is renowned for its development of percutaneous hepatic perfusion (PHP) technology, a targeted therapy for the treatment of primary and metastatic liver cancers. Delcath's flagship product, the CHEMOSAT/Melphalan HDS system, is designed to administer high-dose chemotherapy directly to the liver while controlling systemic exposure and reducing side effects. This innovative approach aims to improve cancer control and patient outcomes, positioning Delcath Systems at the forefront of interventional oncology. The company holds significant ambitions to expand the therapeutic applications of its PHP technology into other areas of unmet medical need in oncology.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Delcath Systems, Inc. as of June 30, 2025 is 70.24 MM.
- The operating income for Delcath Systems, Inc. as of June 30, 2025 is 5.01 MM.
- The net income for Delcath Systems, Inc. as of June 30, 2025 is 2.23 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 70.24 | 5.01 | 2.23 |
| 2025-03-31 | 53.85 | -1.49 | -14.21 |
| 2024-12-31 | 37.20 | -12.41 | -26.39 |
| 2024-09-30 | 22.64 | -26.75 | -34.12 |
| 2024-06-30 | 11.88 | -36.05 | -56.33 |
| 2024-03-31 | 4.61 | -40.13 | -49.79 |
| 2023-12-31 | 2.06 | -38.18 | -47.68 |
| 2023-09-30 | 2.17 | -34.73 | -45.01 |
| 2023-06-30 | 2.64 | -32.35 | -33.55 |
| 2023-03-31 | 2.94 | -33.84 | -36.51 |
| 2022-12-31 | 2.72 | -33.85 | -36.51 |
| 2022-09-30 | 4.19 | -30.66 | -33.38 |
| 2022-06-30 | 3.81 | -29.18 | -31.63 |
| 2022-03-31 | 3.54 | -26.14 | -27.90 |
| 2021-12-31 | 3.56 | -24.53 | -25.65 |
| 2021-09-30 | 1.95 | -26.85 | -27.33 |
| 2021-06-30 | 1.90 | -25.14 | -25.20 |
| 2021-03-31 | 1.74 | -22.96 | -23.04 |
| 2020-12-31 | 1.65 | -21.30 | -24.16 |
| 2020-09-30 | 1.66 | -18.06 | -4.63 |
Income Statement: EPS
- The earnings per share basic for Delcath Systems, Inc. as of June 30, 2025 is 0.07.
- The earnings per share diluted for Delcath Systems, Inc. as of June 30, 2025 is 0.06.
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | 0.07 | 0.06 |
| 2025-03-31 | -0.46 | -0.45 |
| 2024-12-31 | -0.93 | |
| 2024-09-30 | -1.30 | -1.30 |
| 2024-06-30 | -2.39 | -2.39 |
| 2024-03-31 | -2.55 | -2.55 |
| 2023-12-31 | -2.94 | |
| 2023-09-30 | -3.48 | -3.47 |
| 2023-06-30 | -3.11 | -3.11 |
| 2023-03-31 | -3.75 | -3.75 |
| 2022-12-31 | -4.12 | |
| 2022-09-30 | -4.00 | -4.00 |
| 2022-06-30 | -3.98 | -3.98 |
| 2022-03-31 | -3.69 | -3.69 |
| 2021-12-31 | -3.59 | |
| 2021-09-30 | -4.25 | -4.25 |
| 2021-06-30 | -4.49 | -4.49 |
| 2021-03-31 | -5.13 | -5.13 |
| 2020-12-31 | -8.35 | |
| 2020-09-30 | -2.91 | -2.91 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Delcath Systems, Inc. as of June 30, 2025 is 4.85 MM.
- The cash from investing activities for Delcath Systems, Inc. as of June 30, 2025 is -41.49 MM.
- The cash from financing activities for Delcath Systems, Inc. as of June 30, 2025 is 56.13 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 4.85 | -41.49 | 56.13 |
| 2025-03-31 | -6.89 | -30.79 | 38.64 |
| 2024-12-31 | -18.68 | -0.98 | 39.41 |
| 2024-09-30 | -25.85 | -5.42 | -0.97 |
| 2024-06-30 | -31.37 | -4.72 | 36.24 |
| 2024-03-31 | -36.57 | -15.05 | 39.10 |
| 2023-12-31 | -31.25 | -19.71 | 51.78 |
| 2023-09-30 | -30.43 | -0.04 | 57.02 |
| 2023-06-30 | -26.45 | -0.11 | 26.84 |
| 2023-03-31 | -22.84 | -0.12 | 26.84 |
| 2022-12-31 | -24.95 | -0.21 | 10.14 |
| 2022-09-30 | -23.62 | -0.21 | 8.82 |
| 2022-06-30 | -23.35 | -0.20 | 18.43 |
| 2022-03-31 | -24.41 | -0.22 | 18.45 |
| 2021-12-31 | -22.60 | -0.14 | 20.82 |
| 2021-09-30 | -21.61 | -0.22 | 39.78 |
| 2021-06-30 | -21.45 | -0.65 | 25.50 |
| 2021-03-31 | -22.21 | -0.61 | 44.85 |
| 2020-12-31 | -22.87 | -0.78 | 42.35 |
| 2020-09-30 | -23.20 | -0.73 | 19.45 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/book for Delcath Systems, Inc. as of June 30, 2025 is 5.67.
- The p/tbv for Delcath Systems, Inc. as of June 30, 2025 is 5.67.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | 5.67 | 5.67 | |
| 2025-03-31 | 6.39 | 6.39 | |
| 2024-12-31 | -11.14 | 44.36 | 44.36 |
| 2024-09-30 | -4.54 | 61.02 | 61.02 |
| 2024-06-30 | -4.59 | 15.64 | 15.64 |
| 2024-03-31 | -2.43 | 7.34 | 7.34 |
| 2023-12-31 | -2.04 | 3.01 | 3.01 |
| 2023-09-30 | -1.84 | 17.44 | 17.44 |
| 2023-06-30 | -1.68 | -4.69 | -4.69 |
| 2023-03-31 | -1.58 | -9.87 | |
| 2022-12-31 | -6.89 | -6.89 | |
| 2022-09-30 | -9.67 | -9.67 | |
| 2022-06-30 | 6.04 | 6.04 | |
| 2022-03-31 | -1.99 | 4.27 | 4.27 |
| 2021-12-31 | -2.10 | 4.89 | 4.89 |
| 2021-09-30 | -3.03 | 5.04 | 5.04 |
| 2021-06-30 | |||
| 2021-03-31 | -1.71 | 1.97 | 1.97 |
| 2020-12-31 | -1.57 | 1.71 | 1.71 |
| 2020-09-30 | -5.49 | 7.77 | 7.77 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Delcath Systems, Inc. as of June 30, 2025 is -0.03.
- The ebit (3y)/ev for Delcath Systems, Inc. as of June 30, 2025 is -0.08.
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | -0.03 | -0.08 |
| 2025-03-31 | -0.06 | -0.09 |
| 2024-12-31 | -0.09 | -0.10 |
| 2024-09-30 | -0.21 | -0.17 |
| 2024-06-30 | -0.21 | -0.16 |
| 2024-03-31 | -0.39 | -0.30 |
| 2023-12-31 | -0.67 | -0.52 |
| 2023-09-30 | -0.55 | -0.49 |
| 2023-06-30 | -0.78 | -0.66 |
| 2023-03-31 | -0.55 | -0.44 |
| 2022-12-31 | -0.75 | -0.50 |
| 2022-09-30 | -0.91 | -0.62 |
| 2022-06-30 | -0.87 | -0.64 |
| 2022-03-31 | -0.59 | -0.44 |
| 2021-12-31 | -0.57 | -0.42 |
| 2021-09-30 | -0.43 | -0.35 |
| 2021-06-30 | ||
| 2021-03-31 | -1.55 | -1.49 |
| 2020-12-31 | -1.82 | -1.31 |
| 2020-09-30 | -0.25 | -1.16 |
Management Effectiveness
- The roa for Delcath Systems, Inc. as of June 30, 2025 is -0.42.
- The roe for Delcath Systems, Inc. as of June 30, 2025 is -3.39.
- The roic for Delcath Systems, Inc. as of June 30, 2025 is -0.17.
- The croic for Delcath Systems, Inc. as of June 30, 2025 is 0.01.
- The ocroic for Delcath Systems, Inc. as of June 30, 2025 is -0.08.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | -0.42 | -3.39 | -0.17 | 0.01 | -0.08 |
| 2025-03-31 | -0.73 | -1.80 | -0.37 | 0.27 | -0.26 |
| 2024-12-31 | -0.88 | -2.16 | -2.93 | -2.77 | -2.22 |
| 2024-09-30 | -1.18 | -2.28 | -3.95 | 0.01 | -2.20 |
| 2024-06-30 | -1.63 | -4.87 | -1.63 | -0.41 | -1.20 |
| 2024-03-31 | -2.67 | -1.70 | 0.03 | -1.12 | |
| 2023-12-31 | -2.23 | -1.29 | 0.76 | -0.87 | |
| 2023-09-30 | -1.59 | -2.49 | 0.02 | -1.97 | |
| 2023-06-30 | -1.73 | -2.53 | 0.02 | ||
| 2023-03-31 | -1.34 | -6.99 | -13.14 | 1.36 | -8.22 |
| 2022-12-31 | -0.92 | -2.70 | -2.82 | -1.34 | -2.10 |
| 2022-09-30 | -0.88 | -2.59 | -2.86 | -1.36 | -2.13 |
| 2022-06-30 | -1.09 | -1.79 | -2.27 | -0.38 | -1.74 |
| 2022-03-31 | -0.79 | -1.28 | -1.27 | -0.29 | -1.14 |
| 2021-12-31 | -0.79 | -1.24 | -0.92 | -0.06 | -0.76 |
| 2021-09-30 | -1.65 | -7.69 | -1.89 | 1.24 | -1.20 |
| 2021-06-30 | -1.23 | -3.27 | -1.41 | 0.18 | -1.20 |
| 2021-03-31 | -2.36 | -1.01 | 0.96 | -0.97 | |
| 2020-12-31 | -1.70 | 3.80 | -0.89 | 0.69 | -0.85 |
| 2020-09-30 | -0.25 | -0.55 | -0.53 | -2.82 |
Gross Margins
- The gross margin for Delcath Systems, Inc. as of June 30, 2025 is 0.85.
- The net margin for Delcath Systems, Inc. as of June 30, 2025 is -0.26.
- The operating margin for Delcath Systems, Inc. as of June 30, 2025 is -0.03.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 0.85 | -0.26 | -0.03 |
| 2025-03-31 | 0.83 | -0.71 | -0.33 |
| 2024-12-31 | 0.81 | -1.51 | -1.18 |
| 2024-09-30 | 0.77 | -4.74 | -3.04 |
| 2024-06-30 | 0.71 | -10.81 | -8.71 |
| 2024-03-31 | 0.69 | -23.09 | -18.49 |
| 2023-12-31 | 0.68 | -20.79 | -16.04 |
| 2023-09-30 | 0.70 | -12.72 | -12.27 |
| 2023-06-30 | 0.72 | -12.72 | -12.27 |
| 2023-03-31 | 0.75 | -12.43 | -11.52 |
| 2022-12-31 | 0.86 | -7.57 | -6.92 |
| 2022-09-30 | 0.85 | -7.57 | -6.92 |
| 2022-06-30 | 0.83 | -7.97 | -7.33 |
| 2022-03-31 | 0.81 | -7.65 | -7.15 |
| 2021-12-31 | 0.62 | -7.21 | -6.90 |
| 2021-09-30 | 0.63 | -13.99 | -13.74 |
| 2021-06-30 | 0.63 | -13.28 | -13.24 |
| 2021-03-31 | 0.61 | -13.24 | -13.19 |
| 2020-12-31 | 0.61 | -14.68 | -12.94 |
| 2020-09-30 | 0.57 | -2.80 | -10.91 |
Identifiers and Descriptors
| Central Index Key (CIK) | 872912 |
Industry Groups
| SIC 3841 - Surgical and Medical Instruments and Apparatus |
